Rocket Pharmaceuticals (RCKT) Tops Q4 EPS by 5c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q4 EPS of ($0.38), $0.05 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Evercore ISI Upgrades The Macerich Company (MAC) to Outperform, 'improving balance sheet and accelerating FFO growth'
• Goldman Sachs Starts Tempus AI Inc (TEM) at Neutral
• Fluence Energy Inc. (FLNC) PT Lowered to $6 at Mizuho